FRIPRO awards hang high and are awarded in fierce competition. Expected approval is around five percent in the coming years. This means that only the best researchers with particularly good applications have the opportunity to reach the top. The academically innovative character and scientific quality of the projects (the assessment criteria Research quality – potential for moving the research frontier and Research quality – quality in R&D activities) are the most important when applications are selected for funding from FRIPRO.
Dean Ivar Gladhaug is very pleased with this year's award. - It is gratifying to see that five of our research communities have won with their applications this year, he says and congratulates Joel Glover, Kevin Sean O'Connell, Ingrid Agartz, Stian Foss and Evandro Fei Fang on the award, and wishes them the best of luck the work.
Five research projects at MED are awarded FRIPRO funds
Fripro renewal: Joel Glover at the Institute of Basic Medical Sciences (IMB) is awarded 9,6 million for pioneering research.
Project: Unlocking molecular diversity in the brain-to-body gateway: spatial transcriptomics and proteomics of brainstem-to-spinal cord projections.
Read more at the IMB webpage (in Norwegian).
Fripro renewal: Evandro Fei Fang at the Institute of Clinical Medicine is awarded 9,6 million for pioneering research.
Project: Defective mitophagy in Alzheimer Tau pathology: Mechanistic studies and AI-based drug development (‘AM-AI’).
Read more at the webpage of Klinmed (in Norwegian).
Fripro renewal: Ingrid Agartz at the Institute of Clinical Medicine is awarded 9,6 million for pioneering research.
Project: Uncovering novel clinical characteristics, risk factors and brain phenotypes across the spectrum of adolescent psychosis.
Read more at the webpage of Klinmed (in Norwegian).
Young talents: Kevin O'Connell at SFF Norment, at the Institute of Clinical Medicine is awarded 8 million for pioneering research.
Project: Prediction and Stratification of Substance Use in Bipolar Disorder to Improve Disease Outcome (PASS-BD)
Read more at the webpage of Klinmed (in Norwegian).
Young talents: Stian Foss at the Institute of Clinical Medicine is awarded 8 million for pioneering research.
Project: Engaging intracellular immunity to eradicate neurodegenerative disease
Read more at the webpage of Klinmed (in Norwegian).
Read more in Norwegian